INTERSECT ENT INC (XENT) Stock News

NASDAQ:XENT - Nasdaq - US46071F1030 - Common Stock

28.24 0 (0%)

After market: 28.24 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

XENT Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Intersect ENT, Inc.

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

4 years ago - By: Zacks Investment Research

Why Is Intersect ENT (XENT) Down 0.6% Since Last Earnings Report?

4 years ago - By: Zacks Investment Research - Mentions: MDT CHE MEDP

Intersect ENT's (XENT) Sell-Off on Track Amid COVID Woes

4 years ago - By: Zacks Investment Research

Intersect ENT (XENT) Reports Q3 Loss, Lags Revenue Estimates

4 years ago - By: Intersect ENT, Inc.

Intersect ENT Reports Third Quarter 2021 Financial Results

4 years ago - By: Intersect ENT®, Inc.

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

4 years ago - By: Zacks Investment Research

Analysts Estimate Intersect ENT (XENT) to Report a Decline in Earnings: What to Look Out for

4 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intersect ENT, Inc. - XENT

4 years ago - By: Halper Sadeh LLP - Mentions: INOV LMRK JAX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Halper Sadeh LLP - Mentions: GTS INOV XONE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Halper Sadeh LLP - Mentions: CSOD FFWM RIVE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm